Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Times Interest Earned (2016 - 2025)

Guided Therapeutics' Times Interest Earned history spans 15 years, with the latest figure at -$3.76 for Q3 2025.

  • For Q3 2025, Times Interest Earned rose 27.62% year-over-year to -$3.76; the TTM value through Sep 2025 reached -$3.87, up 40.05%, while the annual FY2024 figure was -$5.53, 55.51% up from the prior year.
  • Times Interest Earned for Q3 2025 was -$3.76 at Guided Therapeutics, up from -$4.86 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.91 in Q3 2021 and bottomed at -$21.83 in Q2 2023.
  • The 5-year median for Times Interest Earned is -$5.19 (2024), against an average of -$6.66.
  • The largest annual shift saw Times Interest Earned soared 65.31% in 2021 before it tumbled 763.85% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at -$4.35 in 2021, then plummeted by 211.33% to -$13.54 in 2022, then surged by 50.26% to -$6.74 in 2023, then skyrocketed by 40.95% to -$3.98 in 2024, then rose by 5.48% to -$3.76 in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Times Interest Earned are -$3.76 (Q3 2025), -$4.86 (Q2 2025), and -$2.82 (Q1 2025).